| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 07/03/2001 | CA2006222C Enhanced chemiluminescence from 1,2-dioxetanes through energy transfer to tethered fluorescers |
| 06/29/2001 | CA2329576A1 Optically active 3-[(2-piperazinylphenyl)methyl]-1-[4-(trifluoromethyl)phenyl]-2-pyrrolidinone compounds as 5-ht1d receptor selective antagonists |
| 06/28/2001 | WO2001046175A1 Diamidine compounds as dna minor groove binders |
| 06/28/2001 | WO2001046141A1 Method for the production of n-alkenyl amides |
| 06/28/2001 | WO2001046140A1 Ep4 receptor selective agonists in the treatment of osteoporosis |
| 06/28/2001 | WO2001046139A1 Method for producing n-alkenyl amides |
| 06/28/2001 | WO2001046138A1 Inhibitors of farnesyl protein transferase |
| 06/28/2001 | WO2001046137A1 Farnesyl transferase inhibitors |
| 06/28/2001 | WO2001046136A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors |
| 06/28/2001 | WO2001046110A2 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
| 06/28/2001 | WO2001045711A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | WO2001045703A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 06/28/2001 | WO2001045700A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | WO2001010834A3 Antibacterial agents |
| 06/28/2001 | WO1999063937A9 Multivalent macrolide antibiotics |
| 06/28/2001 | US20010005725 Antiparasitic compounds such as 4-(2,2-dibromocyclopropyl)-1-(2,6-dichloro-4-trifluoromethylphenyl)-1,2,3 -triazole |
| 06/28/2001 | DE19962933A1 New ascosalipyrrolone derivatives, useful as antibacterials for human or veterinary medicine, produced by new Ascochyta fungus |
| 06/28/2001 | DE19962405A1 Production of N-alkenyl amides, useful for the production of plastics, comprises liquid phase reaction of an NH-amide with acetylene using a basic alkali metal compound and an alkoxy cocatalyst |
| 06/28/2001 | DE19962138A1 Production of N-alkenyl amides, useful for the production of plastics and paint comprises liquid phase reaction of an NH-amide with acetylene using a basic alkali metal compound and a diol cocatalyst |
| 06/28/2001 | DE10060746A1 New divalent or trivalent linking agents, useful for dimerizing proteins and immobilizing them on carriers, comprise thiol-binding group and sulfur-containing functional group |
| 06/28/2001 | CA2395202A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors |
| 06/28/2001 | CA2395191A1 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
| 06/28/2001 | CA2393724A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 06/28/2001 | CA2392150A1 Diamidine compounds as dna minor groove binders |
| 06/28/2001 | CA2388669A1 Inhibitors of farnesyl protein transferase |
| 06/28/2001 | CA2387579A1 Farnesyl transferase inhibitors |
| 06/27/2001 | EP1110954A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 06/27/2001 | EP1110949A1 EP4 receptor selective agonists in the treatment of osteoporosis |
| 06/27/2001 | EP1110556A1 Preventives/remedies for multiple organ failure |
| 06/27/2001 | EP1109816A1 Vinyl substituted cyclic products of the ene-yne reaction |
| 06/27/2001 | EP1109811A2 Pyrrolobenzodiazepines |
| 06/27/2001 | EP1109783A2 Gaba uptake inhibitors having a pyrrolidine structure |
| 06/27/2001 | EP1109554A2 Pipecolic acid derivatives for vision and memory disorders |
| 06/27/2001 | EP1109543A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 06/27/2001 | CN1301265A Novel substituted arylhydroxamic acids as metalloproteinase inhibitors |
| 06/27/2001 | CN1301264A Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
| 06/26/2001 | US6252089 Method of producing 4-hydroxy-2-pyrrolidinone and method of purifying the same |
| 06/26/2001 | US6252088 Coupling a nitrile containin naphthalene compound with a compound containing propionic acid group |
| 06/26/2001 | US6252083 Fungicides, insecticides, nematocides |
| 06/26/2001 | US6251949 Oxime derivatives, hydrazone derivatives and use thereof |
| 06/26/2001 | US6251947 Certain n-(arylpropyl), n-(aryloxyethyl), and n-(arylallyl)-carboxamides, their agriculturally suitable salts used as fungicide to control plant disease by applying an effective amount on the plant |
| 06/26/2001 | US6251919 Administering aniline derivative for therapy of pain |
| 06/26/2001 | US6251907 1-(aryloxyalkyl)-4-(heteroaryl) piperazines and related compounds useful as antipsychotics and analgesics |
| 06/26/2001 | US6251830 Pesticides and herbicides |
| 06/22/2001 | CA2329678A1 Ep4 receptor selective agonists in the treatment of osteoporosis |
| 06/21/2001 | WO2001044324A2 Polymerization of olefins |
| 06/21/2001 | WO2001044223A1 Inhibitors of interleukin 5 gene expression |
| 06/21/2001 | WO2001044190A1 Anthracene derivatives as anti-cancer agents |
| 06/21/2001 | WO2001044181A1 A process for producing crystalline atorvastatin calcium |
| 06/21/2001 | WO2001044180A1 A factory scale process for producing crystalline atorvastatin trihydrate hemi calcium salt |
| 06/21/2001 | WO2001044179A1 Novel succinate compounds, compositions and methods of use and preparation |
| 06/21/2001 | WO2001044178A1 Novel urea compounds, compositions and methods of use and preparation |
| 06/21/2001 | WO2001017955A3 Hydroxyacetamidobenzenesulphonamide derivatives |
| 06/21/2001 | US20010004669 For treatment of depression, anxiety, eating disorders, obesity, drug abuse, cluster headache, migraine, pain and chronic paroxysmal hemicrania and headache associated with vascular disorders |
| 06/21/2001 | US20010004629 Improved toleration by crops, insecticidal and/or spectrum of action |
| 06/21/2001 | DE10061947A1 Oximester-Photostarter Oxime ester photoinitiator |
| 06/21/2001 | CA2395170A1 Anti-cancer agents (iii) |
| 06/21/2001 | CA2393825A1 Novel succinate compounds, compositions and methods of use and preparation |
| 06/21/2001 | CA2393027A1 Inhibitors of interleukin 5 gene expression |
| 06/21/2001 | CA2388226A1 A factory scale process for producing crystalline atorvastatin trihydrate hemi calcium salt |
| 06/20/2001 | EP1109059A2 Oxonol infrared radiation sensitive compounds |
| 06/20/2001 | EP1107953A1 Hydroxamic acid derivatives as proteinase inhibitors |
| 06/20/2001 | EP1107754A1 Ureas and carbamates of n-heterocyclic carboxylic acids and isosteres for vision and memory disorders |
| 06/20/2001 | EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 06/20/2001 | EP1107752A1 Pyrrolidine derivatives for vision and memory disorders |
| 06/20/2001 | EP0890176B1 Proton conductor in liquid form |
| 06/20/2001 | EP0639566B1 Cyclic compound |
| 06/20/2001 | CN1300281A Compounds with growth hormone releasing properties |
| 06/20/2001 | CN1300278A Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 06/20/2001 | CN1300277A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 06/20/2001 | CN1300274A Polyenepolycarboxylic acids, derivatives thereof with respect to carboxyl groups, or salts of these |
| 06/20/2001 | CN1299819A (R)-2[3-(2-N-phthalic amido ethyl)-4,5-dihydro-5-isoxazolyl]-acetic acid and its synthesis |
| 06/20/2001 | CN1299812A Oximate light initiator |
| 06/19/2001 | USRE37234 Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses |
| 06/19/2001 | US6248903 Process for the preparation of methyl (2s)-2-[(3r)-3-(n-{tert-butyloxycarbonyl 9-amino)-2-oxopyrrolidin-1-yl]propionate |
| 06/19/2001 | US6248902 By reaction of gammabutyrolactone and mononmethylamine wherein the synthesis is carried out by a continuous non catalytic process in liquid phase, via three distinct reaction stages connected in series |
| 06/19/2001 | US6248883 Methods of purifying lithium salts |
| 06/19/2001 | US6248775 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 06/19/2001 | US6248755 Antiinflammatory agents; antiallergens; autoimmune diseases |
| 06/19/2001 | US6248743 Antithrombotic agents effective to inhibit the production of type 1 plasminogen activator inhibitor (pai-1) |
| 06/19/2001 | CA2028048C Derivatives of 1,4-dideoxy-1,4-imino-d-mannitol |
| 06/19/2001 | CA2011722C Reagents for the determination of drugs |
| 06/15/2001 | CA2328376A1 Oxime ester photoinitiators |
| 06/14/2001 | WO2001042315A1 Substituted group 4 metal complexes, catalysts and olefin polymerization process |
| 06/14/2001 | WO2001042249A1 Olefin polymerization cocatalysts derived from group-15 compounds and processes using them |
| 06/14/2001 | WO2001042210A1 Amycomycin, a process for its production and its use as a pharmaceutical |
| 06/14/2001 | WO2001042209A1 Process for the preparation of amorphous atorvastatin |
| 06/14/2001 | WO2001042208A1 Cycloamine ccr5 receptor antagonists |
| 06/14/2001 | WO2001042201A1 N-phenylcarbamates having a microbicide, insecticide and acaricide effect |
| 06/14/2001 | WO2001041640A1 Use of poly-nitroxyl-functionalized dendrimers as contrast enhancing agents in mri imaging of joints |
| 06/14/2001 | WO2001005354A3 Improved process for the preparation of benzenesulfonylureas as oral hypoglycemic agents of the second generation |
| 06/14/2001 | WO1999067250A8 Syntheses of a variety of lamellarin compounds and analogues |
| 06/14/2001 | CA2646567A1 Substituted group 4 metal complexes, catalysts and olefin polymerization process |
| 06/14/2001 | CA2391855A1 Olefin polymerization cocatalysts derived from group-15 compounds and processes using them |
| 06/13/2001 | EP1106604A1 Amycomycin, a process for its production and its use as a pharmaceutical |
| 06/13/2001 | EP1105375A1 Trifluoro methylpyrrol carboxamides |
| 06/13/2001 | EP1105131A2 Small molecule carbamates or ureas for vision and memory disorders |
| 06/13/2001 | EP1105130A2 Heterocyclic esters or amides for vision and memory disorders |
| 06/13/2001 | EP1105126A2 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 06/13/2001 | EP1105125A2 Use of sulfonamides for treating vision and memory disorders |